Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.07.07.663471

Investigating Age-Related Decline in Sensorimotor Control Using Robotic Tasks

Abstract

Aging is associated with changes in sensorimotor control that contribute to functional decline, mobility limitations, and increased fall risk. Traditional motor assessments often rely on subjective measures, highlighting the need for objective, quantitative tools. We developed three robot-based tasks using the vBOT planar manipulandum to evaluate sensorimotor performance in healthy young (<35 years) and older (>60 years) adults. These tasks uniquely combined bimanual control and altered dynamic conditions to assess age-related differences. The first task required bimanual coordination to control a virtual 2D arm over 400 center-out and return trials, targeting de novo motor learning. The second task involved unimanual reaching with the dominant hand, consisting of 200 trials in a null-field condition followed by 200 trials with object-like dynamic forces. The third task similarly began with 200 null-field trials and then introduced a viscous force field in the final 200 trials, with fast movements rewarded to encourage peak performance. This task also enabled comparison between dominant and non-dominant arms. All tasks detected age-related performance differences, with the viscous resistance task proving most sensitive to declines in movement speed, force generation, and response onset time. Scoring mechanisms that encouraged brisk performance amplified these effects. Across tasks, older adults generally moved more slowly, took longer to complete tasks, exerted lower peak forces, and had longer response onset times. However, some older participants performed comparably to younger individuals. In the third task, dominant arm performance consistently exceeded that of the non-dominant arm. These results demonstrate that robot-based tasks can sensitively quantify age-related sensorimotor decline and may offer valuable metrics for clinical assessment and monitoring. Significance StatementThis study utilizes a robotic manipulandum, i.e., the vBOT, to assess the effect of aging. Through precisely controlled repeatable sensorimotor tasks, we quantify movement characteristics in both younger and older adults, providing clear insights into age-related motor decline. Our approach not only highlights the magnitude and variability of functional changes with age but also establishes rigorous and reliable quantitative benchmarks that could serve as critical tools for evaluating preventative therapies. In turn, this could guide the development of interventions aimed at preserving motor performance in older age. HighlightsThis study introduces a novel approach to assessing how aging affects movement dynamics using a robotic system. As populations age, understanding sensorimotor decline becomes increasingly crucial. Unlike conventional assessments, our method quantifies motor control metrics with precision, revealing previously undetectable, subtle age-related changes in movement efficiency, response onset times, and force generation. This framework establishes a rigorous benchmark for evaluating age-related decline, offering valuable clinical applications and informing the design of interventions to support older adults.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Alvarez-Hidalgo, L., Edlmann, E., Schmidtmann, G., Howard, I. S.. 2025-07-09. Investigating Age-Related Decline in Sensorimotor Control Using Robotic Tasks. https://doi.org/10.1101/2025.07.07.663471

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗